A Legionella effector modulates host cytoskeletal structure by inhibiting actin polymerization

Microbes Infect. 2014 Mar;16(3):225-36. doi: 10.1016/j.micinf.2013.11.007. Epub 2013 Nov 26.

Abstract

Successful infection by the opportunistic pathogen Legionella pneumophila requires the collective activity of hundreds of virulence proteins delivered into the host cell by the Dot/Icm type IV secretion system. These virulence proteins, also called effectors modulate distinct host cellular processes to create a membrane-bound niche called the Legionella containing vacuole (LCV) supportive of bacterial growth. We found that Ceg14 (Lpg0437), a Dot/Icm substrate is toxic to yeast and such toxicity can be alleviated by overexpression of profilin, a protein involved in cytoskeletal structure in eukaryotes. We further showed that mutations in profilin affect actin binding but not other functions such as interactions with poly-l-proline or phosphatidylinositol, abolish its suppressor activity. Consistent with the fact the profilin suppresses its toxicity, expression of Ceg14 but not its non-toxic mutants in yeast affects actin distribution and budding of daughter cells. Although Ceg14 does not detectably interact with profilin, it co-sediments with filamentous actin and inhibits actin polymerization, causing the accumulation of short actin filaments. Together with earlier studies, these results reveal that multiple L. pneumophila effectors target components of the host cytoskeleton.

Keywords: Intracellular growth; Profilin; Type IV secretion system; Vesicle trafficking.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / antagonists & inhibitors
  • Actins / drug effects
  • Actins / metabolism*
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Bacterial Proteins / pharmacology*
  • HEK293 Cells
  • Host-Pathogen Interactions
  • Humans
  • Legionella / genetics*
  • Legionella / pathogenicity
  • Microbial Viability / drug effects*
  • Plasmids / genetics
  • Polymerization / drug effects
  • Profilins / genetics
  • Profilins / metabolism*
  • Yeasts / drug effects*

Substances

  • Actins
  • Bacterial Proteins
  • Profilins